Same industry

RGEN against four biotech peers, a year at 100

100200400800Feb ’26MayAugNov ’26AMGN+35.7%GILD+34.4%MRNA×8.7BIIB+43.1%RGEN−0.2%

RGEN −0.2%. Moderna ×8.7, Biogen +43.1%, Amgen +35.7%, Gilead Sciences +34.4%. Weekly closes, Nov 21, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in RGEN’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

RGEN: stories, the record and filings →